&Partners’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Buy
9,329
+64
+0.7% +$1.67K ﹤0.01% 2356
2026
Q1
$253K Buy
9,265
+1,631
+21% +$57.9K ﹤0.01% 2098
2025
Q4
$317K Sell
7,634
-666
-8% -$27K ﹤0.01% 1878
2025
Q3
$383K Buy
8,300
+1,266
+18% +$67.5K ﹤0.01% 1616
2025
Q2
$379K Buy
+7,034
New +$372K ﹤0.01% 1490

Other funds holding CNXC

&Partners's CNXC Position: Q2 2026 in Review

&Partners increased its Concentrix (CNXC) stake by 0.69% in Q2 2026, buying an estimated $1.67K and bringing the position to 9,329 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #2356.

&Partners first reported a position in CNXC in Q2 2025 and has held it in 5 quarters since. The position peaked at $383K in Q3 2025. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • &Partners held 9,329 shares of Concentrix worth $209K as of Q2 2026.
  • &Partners bought 64 Concentrix shares in Q2 2026, an estimated $1.67K.
  • Concentrix made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2356 holding.
  • &Partners first reported a position in Concentrix in Q2 2025 and has held it in 5 quarters since.
  • &Partners's Concentrix position peaked at $383K in Q3 2025.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.